Trial intelligence / Profile preview

N1539 (IV Meloxicam) in Abdominal Laparoscopic Surgery

NCT01436032Phase 3Terminated

Sponsor
Alkermes
Start
Oct 2011
Primary completion
Mar 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of meloxicam in postoperative pain, sponsored by Alkermes. Started Oct 2011; status: terminated.

02

Drugs

meloxicam
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT01436032.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01436032.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call